Evaluation of the Efficacy and Safety of Different Duration of Proton Pump Inhibitor for Prevention of Upper Gastrointestinal Mucosal Injury in Patients Taking 12-month Dual Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 03 Nov 2017
At a glance
- Drugs Pantoprazole (Primary)
- Indications Gastric ulcer
- Focus Adverse reactions
- Acronyms DACAB-GI-2
- 29 Oct 2017 Planned End Date changed from 1 Apr 2019 to 1 Mar 2020.
- 29 Oct 2017 Planned initiation date changed from 1 Jun 2017 to 1 Apr 2018.
- 06 Feb 2017 New trial record